Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

CEP76: investigating a novel potential driver of Joubert syndrome

FY 2022-23

Summary
Primary cilia are critical components of most cells, as they are involved in many cell signalling pathways that regulate cellular and organ development. When this process goes wrong, patients develop ciliopathies, which are a genetically and clinically heterogenous group of diseases that cause a wide range of morbidities. One such ciliopathy is Joubert Syndrome, which is characterised by the absence or underdevelopment of the cerebellar vermis, malformed brain stem, and other problems. We identified a proband that we suspect to have Joubert Syndrome, who has retinitis pigmentosa, hypoplastic cerebellar vermis, and oculomotor apraxia. Analysis of their genome and the unaffected genome revealed compound heterozygous variants in trans: a c.307C>T:p.Pro103Ser missense mutation of unknown significance in exon 4, and a deletion in exon 6 that causes a frameshift and loss of function. In silico analyses suggest that c.307C>T in exon 4 is rare in human populations, and CEP76 is conserved across vertebrates. It is also predicted to increase the incidence of alternative splicing, which we confirmed using digital PCR. CEP76 codes for the centrosomal protein CEP76, which has been shown to play a role in regulating mitotic progression by suppressing centriole amplification. CEP76 has only been linked to human disease and retinal degeneration in a single human case. To further validate these variants we developed a ciliation assay from patient-derived fibroblasts, which showed that the proband’s cells have decreased ciliation compared to controls. Using functional experiments, we aim to explore how these variants relate to our proband’s ciliopathy phenotype. We will investigate the localization, cilia structure, CEP76-binding partners, and phenotype caused by the mutated CEP76
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
485978
Name
Nitoiu Alexandra
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
CEP76: investigating a novel potential driver of Joubert syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Biology; Ciliopathy; Genetics; Genome Biology; Joubert Syndrome; Molecular Genetics; Ophthalmology
Abstract
Primary cilia are critical components of most cells, as they are involved in many cell signalling pathways that regulate cellular and organ development. When this process goes wrong, patients develop ciliopathies, which are a genetically and clinically heterogenous group of diseases that cause a wide range of morbidities. One such ciliopathy is Joubert Syndrome, which is characterised by the absence or underdevelopment of the cerebellar vermis, malformed brain stem, and other problems. We identified a proband that we suspect to have Joubert Syndrome, who has retinitis pigmentosa, hypoplastic cerebellar vermis, and oculomotor apraxia. Analysis of their genome and the unaffected genome revealed compound heterozygous variants in trans: a c.307C>T:p.Pro103Ser missense mutation of unknown significance in exon 4, and a deletion in exon 6 that causes a frameshift and loss of function. In silico analyses suggest that c.307C>T in exon 4 is rare in human populations, and CEP76 is conserved across vertebrates. It is also predicted to increase the incidence of alternative splicing, which we confirmed using digital PCR. CEP76 codes for the centrosomal protein CEP76, which has been shown to play a role in regulating mitotic progression by suppressing centriole amplification. CEP76 has only been linked to human disease and retinal degeneration in a single human case. To further validate these variants we developed a ciliation assay from patient-derived fibroblasts, which showed that the proband’s cells have decreased ciliation compared to controls. Using functional experiments, we aim to explore how these variants relate to our proband’s ciliopathy phenotype. We will investigate the localization, cilia structure, CEP76-binding partners, and phenotype caused by the mutated CEP76
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nitoiu, Alexandra
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~